Cargando…

Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus

Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments....

Descripción completa

Detalles Bibliográficos
Autores principales: Bannister, Margaret, Berlanga, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014794/
https://www.ncbi.nlm.nih.gov/pubmed/27502496
http://dx.doi.org/10.1007/s13300-016-0188-5
_version_ 1782452328978186240
author Bannister, Margaret
Berlanga, Jenny
author_facet Bannister, Margaret
Berlanga, Jenny
author_sort Bannister, Margaret
collection PubMed
description Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized treatment pathways, including personalized HbA1c targets, this article will explore the mode of action of currently available oral treatments, factors to consider when individualizing HbA1c targets, the relevance of estimated glomerular filtration rate assessment, and the importance of reviewing the clinical impact of all treatment decisions.
format Online
Article
Text
id pubmed-5014794
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-50147942016-09-19 Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus Bannister, Margaret Berlanga, Jenny Diabetes Ther Commentary Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized treatment pathways, including personalized HbA1c targets, this article will explore the mode of action of currently available oral treatments, factors to consider when individualizing HbA1c targets, the relevance of estimated glomerular filtration rate assessment, and the importance of reviewing the clinical impact of all treatment decisions. Springer Healthcare 2016-08-08 2016-09 /pmc/articles/PMC5014794/ /pubmed/27502496 http://dx.doi.org/10.1007/s13300-016-0188-5 Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Commentary
Bannister, Margaret
Berlanga, Jenny
Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
title Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
title_full Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
title_fullStr Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
title_full_unstemmed Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
title_short Effective Utilization of Oral Hypoglycemic Agents to Achieve Individualized HbA1c Targets in Patients with Type 2 Diabetes Mellitus
title_sort effective utilization of oral hypoglycemic agents to achieve individualized hba1c targets in patients with type 2 diabetes mellitus
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014794/
https://www.ncbi.nlm.nih.gov/pubmed/27502496
http://dx.doi.org/10.1007/s13300-016-0188-5
work_keys_str_mv AT bannistermargaret effectiveutilizationoforalhypoglycemicagentstoachieveindividualizedhba1ctargetsinpatientswithtype2diabetesmellitus
AT berlangajenny effectiveutilizationoforalhypoglycemicagentstoachieveindividualizedhba1ctargetsinpatientswithtype2diabetesmellitus